Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ratner

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Nature Biotechnology|December 5, 2019
Patients with porphyria bask in sunlight of FDA approvalMark Ratner
Nature Biotechnology|December 4, 2020
Microbial cocktails raise bar for C. diff. treatmentsMark Ratner
Nature Biotechnology|September 7, 2018
FDA approves first single-dose antimalarialMark Ratner
Nature Biotechnology|June 10, 2014
First PDE4 inhibitor for psoriasis hits the market but impact is uncertainMark Ratner
Nature Biotechnology|June 9, 2012
The gatekeepers of effectivenessMark Ratner
Nature Biotechnology|February 6, 2016
FDA approves three different multiple myeloma drugs in one monthMark Ratner
Nature Biotechnology|March 7, 2018
Jury out on liquid biopsies for cancerMark Ratner
Nature Biotechnology|February 10, 2021
Light-activated genetic therapy to treat blindness enters clinicMark Ratner
Nature Biotechnology|March 2, 2021
Publisher Correction: Light-activated genetic therapy to treat blindness enters clinicMark Ratner
Nature Biotechnology|August 10, 2016
Genentech's PD-L1 agent approved for bladder cancerMark Ratner
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Nature Biotechnology|December 5, 2019
Patients with porphyria bask in sunlight of FDA approvalMark Ratner
Nature Biotechnology|December 4, 2020
Microbial cocktails raise bar for C. diff. treatmentsMark Ratner
Nature Biotechnology|September 7, 2018
FDA approves first single-dose antimalarialMark Ratner
Nature Biotechnology|June 10, 2014
First PDE4 inhibitor for psoriasis hits the market but impact is uncertainMark Ratner
Nature Biotechnology|June 9, 2012
The gatekeepers of effectivenessMark Ratner
Nature Biotechnology|February 6, 2016
FDA approves three different multiple myeloma drugs in one monthMark Ratner
Nature Biotechnology|March 7, 2018
Jury out on liquid biopsies for cancerMark Ratner
Nature Biotechnology|February 10, 2021
Light-activated genetic therapy to treat blindness enters clinicMark Ratner
Nature Biotechnology|March 2, 2021
Publisher Correction: Light-activated genetic therapy to treat blindness enters clinicMark Ratner
Nature Biotechnology|August 10, 2016
Genentech's PD-L1 agent approved for bladder cancerMark Ratner
Pageof 11